| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC4994 | |||||||||||||||||||||||
| Submitter : | Mrs. jane perdue | Date & Time: | 12/28/2006 09:12:01 | |||||||||||||||||||||
| Organization : | CCL/grand traverse co. | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| RE: vaccination source/production:
I strongly support the FDA using NO cell lines taken from aborted HUMAN babies. thank you for respecting human life at all stages of our development. | ||||||||||||||||||||||||